BACE1 and Alzheimer disease: Also, the β-site of the APP cleaving enzyme 1 (BACE1) activity, measured by using the β-secretase activity fluorometric assay kit, was increased in the hippocampus from AD mice with the vehicle treatment but was backed to the WT levels by the FA treatment (Supplementary Fig. 5b).